Silverfin false 31/12/2022 01/01/2022 31/12/2022 Benjamin Birrell 03/12/2020 Katie Louise Birrell 28/03/2022 Tina Bolding 03/12/2020 Dawn Dowds 28/03/2022 Andrew Philip Murray 23/06/2022 28/03/2022 Zeeus Stone 28/03/2022 13 September 2023 The principal activity of the company continued to be that of group management. 13060328 2022-12-31 13060328 bus:Director1 2022-12-31 13060328 bus:Director2 2022-12-31 13060328 bus:Director3 2022-12-31 13060328 bus:Director4 2022-12-31 13060328 bus:Director5 2022-12-31 13060328 bus:Director6 2022-12-31 13060328 core:CurrentFinancialInstruments 2022-12-31 13060328 core:CurrentFinancialInstruments 2021-12-31 13060328 2021-12-31 13060328 core:ShareCapital 2022-12-31 13060328 core:ShareCapital 2021-12-31 13060328 core:RetainedEarningsAccumulatedLosses 2022-12-31 13060328 core:RetainedEarningsAccumulatedLosses 2021-12-31 13060328 2022-01-01 2022-12-31 13060328 bus:FullAccounts 2022-01-01 2022-12-31 13060328 bus:SmallEntities 2022-01-01 2022-12-31 13060328 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 13060328 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 13060328 bus:Director1 2022-01-01 2022-12-31 13060328 bus:Director2 2022-01-01 2022-12-31 13060328 bus:Director3 2022-01-01 2022-12-31 13060328 bus:Director4 2022-01-01 2022-12-31 13060328 bus:Director5 2022-01-01 2022-12-31 13060328 bus:Director6 2022-01-01 2022-12-31 13060328 2021-01-01 2021-12-31 iso4217:GBP xbrli:pure

Company No: 13060328 (England and Wales)

HAELAN PHARMACAUTICALS LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2022
Pages for filing with the registrar

HAELAN PHARMACAUTICALS LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2022

Contents

HAELAN PHARMACAUTICALS LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2022
HAELAN PHARMACAUTICALS LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2022
DIRECTORS Benjamin Birrell
Katie Louise Birrell
Tina Bolding
Dawn Dowds
Zeeus Stone
SECRETARIES Benjamin Birrell
Tina Bolding
REGISTERED OFFICE Gascoyne House
Fornham All Saints
Bury St. Edmunds
IP28 6JY
England
United Kingdom
COMPANY NUMBER 13060328 (England and Wales)
CHARTERED ACCOUNTANTS Gascoynes
Gascoyne House
Moseleys Farm Business Centre
Fornham All Saints
Bury St Edmunds
Suffolk
IP28 6JY
HAELAN PHARMACAUTICALS LIMITED

BALANCE SHEET

As at 31 December 2022
HAELAN PHARMACAUTICALS LIMITED

BALANCE SHEET (continued)

As at 31 December 2022
2022 2021
£ £
Current assets
Debtors 3 26,680 80
Cash at bank and in hand 5,000 0
31,680 80
Creditors: amounts falling due within one year 4 ( 26,836) 0
Net current assets 4,844 80
Total assets less current liabilities 4,844 80
Net assets 4,844 80
Capital and reserves
Called-up share capital 1,600 80
Profit and loss account 3,244 0
Total shareholders' funds 4,844 80

For the financial year ending 31 December 2022 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Haelan Pharmacauticals Limited (registered number: 13060328) were approved and authorised for issue by the Board of Directors on 13 September 2023. They were signed on its behalf by:

Dawn Dowds
Director
HAELAN PHARMACAUTICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
HAELAN PHARMACAUTICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2022
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Haelan Pharmacauticals Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Gascoyne House, Fornham All Saints, Bury St. Edmunds, IP28 6JY, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

2. Employees

2022 2021
Number Number
Monthly average number of persons employed by the Company during the year, including directors 5 2

3. Debtors

2022 2021
£ £
Amounts owed by Group undertakings 25,080 0
Other debtors 1,600 80
26,680 80

4. Creditors: amounts falling due within one year

2022 2021
£ £
Amounts owed to Group undertakings 26,836 0

5. Related party transactions

Transactions with the entity's directors

2022 2021
£ £
D Dowds 190 0
B Birrell 700 0
T Bolding 700 0

Balances owed by B Birrell and D Dowds are all cleared within 9 months of the end of the period.